Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy

6125 Background: Myelosuppression represents the major dose-limiting toxicity of cancer chemotherapy. A prospective, nationwide study was undertaken to define risk factors for neutropenic complicat...